Acid Lipase Deficiency Market– CAGR of 11.30% Forecast to 2030
Lysosomal acid lipase (LAL) deficiency is a rare inherited condition in which the body does not produce enough lysosomal acid lipase (LAL) enzyme, an important enzyme for the breakdown of fatty materials such as cholesteryl esters and triglycerides. As a result, a large amount of fatty material accumulates in body organs such as the spleen, liver, and gut. Wolman disease (WD) and Cholesteryl Ester Storage Disease are two autosomal recessive disorders caused by LAL deficiency (CESD). LAL deficiency is caused by a genetic mutation in the LIPA gene, resulting in a decrease or loss of the Lysosomal Acid Lipase (LAL) enzyme.
Browse Related Report:

Comments
Post a Comment